MMM Medicine Made to Measure

MMM Medicine Made to Measure is an Innovative Training Network funded by the European Union under the Horizon Europe Marie Skłodowska-Curie Actions scheme.

Its aim is to develop single patient tailored antisense oligonucleotide (ASO) treatments for patients with nano-rare disease mutations. For this purpose, 10 doctoral candidates will be recruited to research the core modules of tailored ASO treatments to nano-rare RND patients